Yamate S, Ishiguro C, Fukuda H, Hamai S, Nakashima Y.
Continuous co-prescription of rebamipide prevents upper gastrointestinal bleeding in NSAID use for orthopaedic conditions: A nested case-control study using the LIFE Study database.
Plos One 2024; 19(6):e0305320
Murata F, Maeda M, Murayama K, Nakao T, Fukuda H.
Incidence of post-COVID psychiatric disorders according to the periods of SARS-CoV-2 variant dominance: The LIFE Study.
Journal of Psychiatric Research 2024; 174: 12-18.
Yamaguchi Y, Murata F, Maeda M, Fukuda H.
Investigating the Epidemiology and Outbreaks of Scabies in Japanese Households, Residential Care Facilities, and Hospitals Using Claims Data: The LIFE Study.
IJID Regions 2024; 11: 100353.
Tamada Y, Kusama T, Maeda M, Murata F, Osaka K, Fukuda H, Takeuchi K.
Validity of Claims-based Definition of Number of Remaining Teeth in Japan: Results from the Longevity Improvement and Fair Evidence Study.
Plos One 2024; 19(5): e0299849
Murata F, Maeda M, Murayama K, Nakao T, Fukuda H.
Associations between COVID-19 vaccination and incident psychiatric disorders after breakthrough SARS-CoV-2 infection: The VENUS Study.
Brain Behavior and Immunity 2024; 117: 521-528.
Murata F, Maeda M, Ono R, Fukuda H.
Association Between Regular Physical Activity and Pneumonia-Related Hospitalization According to Pneumococcal Vaccination Status: The VENUS Study.
Vaccine 2024; 42(6): 1268-1274.
Tamada Y, Takeuchi K, Kusama T, Maeda M, Murata F, Osaka K, Fukuda H.
Bivalent mRNA Vaccine Effectiveness and Hybrid Immunity against COVID-19 among Older Adults in Japan: A Test-negative Study from the VENUS Study.
BMC Infectious Diseases 2024; 24(1): 135.
Kim S, Maeda M, Murata F, Fujii T, Ueda E, Ono R, Fukuda H.
Impact of Concurrent Visual and Hearing Impairment on Incident Alzheimer’s Disease: The LIFE Study.
Journal of Alzheimer’s Disease 2024; 98(1):197-207.
Yamada N, Nakatsuka K, Tezuka M, Murata F, Maeda M, Akisue T, Fukuda H, Ono R.
Pneumococcal vaccination coverage and vaccination-related factors among older adults in Japan: LIFE Study.
Vaccine 2024; 42(2): 239-245.
Sato S, Katsuta T, Kawazoe Y, Takahashi M, Murata F, Maeda M, Fukuda H, Kamidani S.
Immune thrombocytopenic purpura and Guillain-Barré syndrome after 23-valent pneumococcal polysaccharide vaccination in Japan: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study.
Vaccine 2024; 12: e16780.